- Home
- NWTG vs TOVX Comparison
NWTG vs TOVX Comparison
Compare NWTG & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NWTG | TOVX |
|---|---|---|
| Founded | 2018 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 6.4M |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | NWTG | TOVX |
|---|---|---|
| Price | $1.63 | $0.17 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 21.0K | ★ 5.8M |
| Earning Date | 01-01-0001 | 06-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 89.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $128.27 | N/A |
| Revenue Next Year | $70.26 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.82 | $0.16 |
| 52 Week High | $3.50 | $1.50 |
Technical Indicators
Market Signals| Indicator | NWTG | TOVX |
|---|---|---|
| Relative Strength Index (RSI) | 50.31 | 41.68 |
| Support Level | $1.51 | $0.17 |
| Resistance Level | $1.62 | $0.26 |
| Average True Range (ATR) | 0.10 | 0.01 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 45.45 | 3.91 |
Price Performance
Historical ComparisonAbout NWTG Newton Golf Company Inc.
Newton Golf Co Inc is a technology-forward golf company dedicated to revolutionizing the sport with cutting-edge, high-performance products. The company's expanding portfolio includes golf shafts, putters, grips, and other golf-related accessories designed for golfers of all skill levels. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf, as well as through mass merchants and corporate customers in the Americas, Asia, and Europe.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.